CIT, Stemina Ink Distribution Deal for Stem Cell-based Assay

CIT will distribute Stemina's devTOX assay in Europe, and the two companies will develop other technologies to assess the safety of compounds for animal and human use.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories